InvestorsHub Logo
Followers 5
Posts 859
Boards Moderated 0
Alias Born 09/28/2012

Re: rod5247 post# 5274

Friday, 06/23/2017 11:06:54 AM

Friday, June 23, 2017 11:06:54 AM

Post# of 8553
All else being equal, I think this will put a floor under $14. But how do we get back to $25 without positive PEG20 news on the phase 3 trial?

Maybe a string of good news: revenue growth acceleration, a new Enhanze partneship, Darzalex and Perjeta in phase 3, Lilly targets in the clinic, positive data on the Keytruda trial, SC herceptin filing.

Any other potential catalysts?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News